Search

1. Isomorphic Labs in Talks at a $40–50B Valuation; No Drug Yet in Human Trials

   

   …ital led, Alphabet/GV/Temasek/MGX/CapitalG). No AI-designed drug has ever entered a human trial; first trials …

   Stories·Oct 8

2. OpenAI in Talks for $30B Round at $1.4T Valuation, With UAE Funds and BlackRock Circling

   

   …nds including Abu Dhabi-based MGX to anchor a funding round of at least $30 billion, with the UAE consortium w…

   Stories·Oct 6